JRC Publications Repository

JRC Publications Repository >

Browsing by Author MORGENSTERN A.

Sort by: In order: Results/Page Authors/Record:
Showing results 1 to 13 of 13
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2002Age Determination of Highly Enriched Uranium. Separation and Analysis of 231Pa.MORGENSTERN A.; APOSTOLIDIS Christos; MAYER KlausArticles in Journals
2002Analysis of 237Np in Spent Fuel Solutions.MORGENSTERN A.; APOSTOLIDIS Christos; OTTMAR Herbert; MAYER KlausArticles in Journals
2005Cyclotron Production of Ac-225 for Targeted Alpha Therapy.APOSTOLIDIS Christos; MOLINET Roger; MC GINLEY J.; MOELLENBECK J.; MORGENSTERN A.Articles in Journals
2002Determination of the Age of Highly Enriched Uranium.WALLENIUS Maria; MORGENSTERN A.; APOSTOLIDIS Christos; MAYER KlausArticles in Journals
2005Development of Analytical Methods for Safeguarding Nuclear Material at the Institute for Transuranium Elements.MAYER Klaus; OTTMAR Herbert; VAN BELLE P.; ABOUSAHL Said; BETTI Maria; TAMBORINI Gabriella; WALLENIUS Maria; MORGENSTERN A.Articles in Journals
2004Fluorescence Spectrocopy on Protactinium(IV) in Aqueous Solution.MARQUART C.m.; PANAK P.j.; APOSTOLIDIS Christos; MORGENSTERN A.; WALTHER C.; KLENZE R.; FANGHAENEL T.Articles in Journals
2004Importance of Receptor Density in Alpha Radioimmunotherapy in B Cell Malignancies: an In-vitro Study.VANDENBULCKE Katja; THIERENS H.; OFFNER Fritz; JANSSENS A.; DE GELDER V.; BACHER K.; PHILIPPE Jan; DE VOS F.; DIERCKX R.; APOSTOLIDIS Christos, et alArticles in Journals
2005In Vitro Evaluation of High-LET 213Bi-Therapy Combined to Other Therapeutic Agents for the Treatment of B-CLL.VANDENBULCKE Katja; THIERENS H.; DE VOS F.; PHILIPPE Jan; OFFNER Fritz; APOSTOLIDIS Christos; MORGENSTERN A.; BACHER K.; DE GELDER V.; DIERCKX R., et alArticles in Journals
2001Separation of 248Cm from a 252Cf Neutron Source for Production of Cm Targets.MALMBECK R.; APOSTOLIDIS Christos; CARLOS R.; GLATZ Jean paul; MOLINET Roger; MORGENSTERN A.; NICHOLL Adrian felim; PAGLIOSA G.; ROEMER K.; SCHAEDEL M., et alArticles in Journals
2004Sequential Therapy with Cytarabine and Bismuth-213 (213BI)-Labeled-HuM195(Anit-CD33) for Acute Myeloid Leukemia (AML).MULFORD D.a.; PANDIT-TASKAR N.; MC DEVITT M.r.; FINN R.d.; APOSTOLIDIS Christos; MORGENSTERN A.; DIVGI C.r.; LARSON S.m.; SCHEINBERG D.a.; JURCIC J.g.Contributions to Conferences
2002Single-Column Extraction Chromatographic Separation of U, Np, Pu and Am.MORGENSTERN A.; APOSTOLIDIS Christos; CARLOS-MARQUEZ R.; MAYER Klaus; MOLINET RogerArticles in Journals
2005Targeted Alpha Therapy with 213 Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer.QU Chang f.; SONG Yang j.; LI Yong; RIZVI S.m.a.; RAJA Chand; SMITH R.; MORGENSTERN A.; APOSTOLIDIS Christos; ALLEN B.j.Articles in Journals
2004Zur Elektronenstruktur metallorganischer Komplexe der f-Elemente. 60(1) Strukturelle, einkristalloptische und magnetooptische Untersuchungen von Trialkylphosphat-Abdukten des Grundkoerpers .......APOSTOLIDIS Christos; MORGENSTERN A.; WALTER O.; REDDMANN H.; AMBERGER H.-d.Articles in Journals
Showing results 1 to 13 of 13

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top